Department of Biomedical Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41100 Modena Italy.
Anticancer Res. 2009 Nov;29(11):4529-33.
Microparticles are used for controlled drug delivery. With the aim of improving both bioavailability and tamoxifen selective toxicity, the activity of tamoxifen embedded in calcium alginate/chitosan microparticles was studied.
Tamoxifen alone and embedded in microparticles prepared with sodium alginate from Kelco (62% mannuronic acid and 38% guluronic acid) and from Fluka (30% mannuronic acid and 70% guluronic acid) was added to MCF-7 and Vero cultures and evaluated for antiproliferative activity by the MTT test.
The use of Kelco or Fluka alginate resulted in different LD(50) values on Vero and MCF-7 cultures, showing a higher cytotoxicity toward Vero cells treated with tamoxifen embedded in Kelco microparticles (25 microM vs. 48 microM on MCF-7 cells) but a selective toxicity with Fluka microparticles (25 microM and 10 microM on Vero and MCF-7 cells respectively).
Microparticle formulation may improve selective toxicity according to the alginate employed: differences in the chemical alginate composition can dramatically change both drug activity and toxicity.
微粒体被用于控制药物的释放。为了提高生物利用度和他莫昔芬的选择性毒性,研究了包埋在海藻酸钠/壳聚糖微粒体中的他莫昔芬的活性。
将单独的他莫昔芬和用 Kelco(62%甘露糖醛酸和 38%古洛糖醛酸)和 Fluka(30%甘露糖醛酸和 70%古洛糖醛酸)海藻酸钠制备的微粒体中的他莫昔芬加入 MCF-7 和 Vero 培养物中,并通过 MTT 试验评估其抗增殖活性。
使用 Kelco 或 Fluka 海藻酸钠在 Vero 和 MCF-7 培养物上产生了不同的 LD(50) 值,表明用 Kelco 微粒体包埋的他莫昔芬对 Vero 细胞的细胞毒性更高(25 microM 对 MCF-7 细胞为 48 microM),但 Fluka 微粒体具有选择性毒性(25 microM 和 10 microM 对 Vero 和 MCF-7 细胞)。
根据所用的海藻酸钠,微粒体制剂可以提高选择性毒性:海藻酸钠的化学成分差异会极大地改变药物的活性和毒性。